The Recall Desk
ModerateFDA (Food)·F-0725-2022·Announced 2022-02-16

Caffeine vitamin supplement tablets recalled for manufacturing deviations

ULTRAtab Laboratories is voluntarily recalling 1,393,353 caffeine supplement tablets due to manufacturing practice deviations.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: FDA Class II voluntary recall for manufacturing deviations. No specific contamination or illness is mentioned in the source.

Plain-English summary

ULTRAtab Laboratories, Inc. is recalling 1,393,353 tablets of its Caffeine 175 mg supplement product containing B6 and B12 vitamins. The recall was initiated on October 6, 2021, due to Current Good Manufacturing Practice (cGMP) deviations identified in the production process.

The bulk product was distributed to 2 distributors located in New York and Florida, who may have repackaged and further distributed the finished product. This recall was classified by the FDA as Class II and was terminated on September 1, 2022.

Consumers who have purchased this product should stop using it and contact ULTRAtab Laboratories for further information about the recall.

The recalled product

Product
Caffeine 175 mg with B6 and B12 vitamins (supplement), ULTRAtab Laboratories, Inc., Highland, NY
Manufacturer
ULTRAtab Laboratories, Inc.
Category
Food — Dietary Supplement
Hazard
  • manufacturing-deviation

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Product Codes: M962L Bulk Lots: 19E032
  • 19E033

Distribution

Distributed in 2 states:

  • FL
  • NY

Related recalls

Same category